BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 12433813)

  • 1. Toxicokinetics and metabolism of N-[(14)C]N-methyl-2-pyrrolidone in male Sprague-Dawley rats: in vivo and in vitro percutaneous absorption.
    Payan JP; Boudry I; Beydon D; Fabry JP; Grandclaude MC; Ferrari E; André JC
    Drug Metab Dispos; 2003 May; 31(5):659-69. PubMed ID: 12695356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy- N-methyl-2-pyrrolidone, N-methylsuccinimide and 2-hydroxy- N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker.
    Jönsson BA; Akesson B
    Int Arch Occup Environ Health; 2003 May; 76(4):267-74. PubMed ID: 12684812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism.
    Ligocka D; Lison D; Haufroid V
    Arch Toxicol; 2003 May; 77(5):261-6. PubMed ID: 12734639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine following oral administration of NMP to rats.
    Carnerup MA; Saillenfait AM; Jönsson BA
    Food Chem Toxicol; 2005 Sep; 43(9):1441-7. PubMed ID: 15951091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue distribution and excretion of N-methyl-2-pyrrolidone in male and female rats.
    Sitarek K; Kilanowicz A
    Int J Occup Med Environ Health; 2006; 19(2):142-8. PubMed ID: 17128812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicokinetics and metabolism of N-[14C]methylpyrrolidone in male Sprague-Dawley rats. A saturable NMP elimination process.
    Payan JP; Beydon D; Fabry JP; Boudry I; Cossec B; Ferrari E
    Drug Metab Dispos; 2002 Dec; 30(12):1418-24. PubMed ID: 12433813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.